SightfileU.S. market data from official filings

Companies › MXCT

MAXCYTE INC (MXCT)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001287098 · EDGAR filings · Updated 2026-06-22

MAXCYTE INC (MXCT) has reported institutional ownership of 61.0%, with 130 institutional managers holding positions valued at $45.9M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01).

Institutional ownership
61.0%
Institutional managers
130
Reported 13F value
$45.9M
Insider activity
16 trans.
$449.3K net buying
Data flags
1 active
from SEC filings

Latest updates

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, MAXCYTE INC has 130 institutional holders and institutional ownership of 61.0%.

Insider activity

Insiders reported 16 transactions (5 buys, 2 sells) across 10 reporting insiders, with a net reported value of $449.3K.

Data flags from SEC filings

Active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), most recently filed 2026-06-16 (recurring since 2026-03-20) — source filing. The authoritative details are those stated in the filing itself.

Related companies

Spero Therapeutics Inc (SPRO) · CARLSMED INC (CARL) · Assertio Holdings Inc (ASRT) · PMV PHARMACEUTICALS INC (PMVP) · Oramed Pharmaceuticals Inc (ORMP) · CARTESIAN THERAPEUTICS INC (RNAC)

See full history, cross-references and alerts on Sightfile
Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-06-22.